Literature DB >> 10669837

Epithelial-mesenchymal interactions in the pathogenesis of asthma.

S T Holgate1, D E Davies, P M Lackie, S J Wilson, S M Puddicombe, J L Lordan.   

Abstract

During lung development, repair, and inflammation, local production of cytokines (eg, transforming growth factor-beta) and growth factors (eg, epidermal growth factor) by epithelial and mesenchymal cells mediate bidirectional growth control effectively creating an epithelial-mesenchymal trophic unit. In asthma the bronchial epithelium is highly abnormal, with structural changes involving separation of columnar cells from their basal attachments and functional changes including increased expression and release of proinflammatory cytokines, growth factors, and mediator-generating enzymes. Beneath this damaged structure there is an increase in the number of subepithelial myofibroblasts that deposit interstitial collagens causing thickening and increased density of the subepithelial basement membrane. Our recent studies suggest that the extent of epithelial damage in asthma may be the result of impaired epidermal growth factor receptor-mediated repair. In view of the close spatial relationship between the damaged epithelium and the underlying myofibroblasts, we propose that impaired epithelial repair cooperates with the T(H)2 environment to shift the set point for communication within the trophic unit. This leads to myofibroblast activation, excessive matrix deposition, and production of mediators that propagate and amplify the remodeling responses throughout the airway wall.

Entities:  

Mesh:

Year:  2000        PMID: 10669837     DOI: 10.1016/s0091-6749(00)90066-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  114 in total

Review 1.  Onset and outcome of asthma in older adults. A clinician's perspective.

Authors:  Charles E Reed
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Airway inflammation and remodeling in asthma: current concepts.

Authors:  Stephen T Holgate
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 3.  Pharmacotherapy and airway remodelling in asthma?

Authors:  P A Beckett; P H Howarth
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

4.  Local small airway epithelial injury induces global smooth muscle contraction and airway constriction.

Authors:  Jian Zhou; Martha B Alvarez-Elizondo; Elliot Botvinick; Steven C George
Journal:  J Appl Physiol (1985)       Date:  2011-11-23

Review 5.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

6.  Structural changes to airway smooth muscle in cystic fibrosis.

Authors:  S R Hays; R E Ferrando; R Carter; H H Wong; P G Woodruff
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

7.  Long-lived regulatory T cells generated during severe bronchiolitis in infancy influence later progression to asthma.

Authors:  Jason P Lynch; Rhiannon B Werder; Bodie F Curren; Md Al Amin Sikder; Ashik Ullah; Ismail Sebina; Ridwan B Rashid; Vivian Zhang; John W Upham; Geoff R Hill; Raymond J Steptoe; Simon Phipps
Journal:  Mucosal Immunol       Date:  2020-02-17       Impact factor: 7.313

8.  Nascent Lung Organoids Reveal Epithelium- and Bone Morphogenetic Protein-mediated Suppression of Fibroblast Activation.

Authors:  Qi Tan; Xiao Yin Ma; Wei Liu; Jeffrey A Meridew; Dakota L Jones; Andrew J Haak; Delphine Sicard; Giovanni Ligresti; Daniel J Tschumperlin
Journal:  Am J Respir Cell Mol Biol       Date:  2019-11       Impact factor: 6.914

Review 9.  Allergen-induced airway remodelling.

Authors:  C M Lloyd; D S Robinson
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

10.  Der p 2 promotes motility of airway epithelial cell attributing to AKT/GSK3β-associated epithelial-to-mesenchymal transition.

Authors:  Chun-Hsiang Lin; Wei-Chun Wang; Shao-Hsuan Kao
Journal:  Mol Cell Biochem       Date:  2014-06-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.